Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Cancers|November 27, 2021
Oligoprogression in Non-Small Cell Lung CancerDaijiro Harada, Nagio TakigawaCancers|March 29, 2014
The Role of STAT3 in Non-Small Cell Lung CancerDaijiro Harada, Nagio Takigawa, Katsuyuki KiuraBreeding Science|August 11, 2021
Chromosome-level de novo genome assemblies of over 100 plant speciesKenta Shirasawa, Daijiro Harada, Hideki Hirakawa, et al.Acta Medica Okayama|August 24, 2019
Therapeutic Outcomes of 15 Postoperative Bronchopleural Fistulas Including Seven Endoscopic InterventionsTsuyoshi Ueno, Yuho Maki, Ryujiro Sugimoto, et al.The Journal of Dermatology|December 6, 2019
Clinical features and treatment of epidermal growth factor inhibitor-related late-phase papulopustular rashMikiko Tohyama, Makoto Hamada, Daijiro Harada, et al.Experimental and Therapeutic Medicine|April 11, 2022
Radiation-induced enterocolitis after combination therapy with palliative radiotherapy and immune checkpoint inhibitors in patients with metastatic lung cancerKenji Makita, Yasushi Hamamoto, Hiromitsu Kanzaki, et al.Journal of Plant Research|August 2, 2018
Cryopreservation of Marchantia polymorpha spermatozoaTaisuke Togawa, Tohru Adachi, Daijiro Harada, et al.Oncotarget|July 3, 2018
Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancerAkito Hata, Daijiro Harada, Chiyuki Okuda, et al.Anticancer Research|September 15, 2019
Previous Immune Checkpoint Inhibitor Treatment to Increase the Efficacy of Docetaxel and Ramucirumab Combination ChemotherapyDaijiro Harada, Kenji Takata, Shunta Mori, et al.Journal for Immunotherapy of Cancer|October 29, 2021
JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesotheliomaYosuke Miyamoto, Toshiyuki Kozuki, Keisuke Aoe, et al.Pageof 7